Glenview State Bank Trust Department’s Pfizer PFE Stock Holding History

Glenview State Bank Trust Department’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$3.43M	Sell	87,710 -275	-0.3%	-$10.7K	1.05%	27
2021 Q1	$3.19M	Buy	87,985 +3,486	+4%	+$124K	1.03%	27
2020 Q4	$3.11M	Sell	84,499 -4,089	-5%	-$150K	1.08%	27
2020 Q3	$3.08M	Buy	88,588 +9,475	+12%	+$332K	1.17%	25
2020 Q2	$2.45M	Buy	79,113 +3,805	+5%	+$129K	1.01%	28
2020 Q1	$2.33M	Sell	75,308 -583	-0.8%	-$19.9K	1.12%	28
2019 Q4	$2.82M	Sell	75,891 -3,499	-4%	-$125K	1.09%	29
2019 Q3	$2.71M	Sell	79,390 -708	-0.9%	-$25.7K	1.09%	29
2019 Q2	$3.29M	Sell	80,098 -536	-0.7%	-$21.3K	1.37%	23
2019 Q1	$3.25M	Buy	80,634 +211	+0.3%	+$8.45K	1.39%	24
2018 Q4	$3.33M	Sell	80,423 -2,425	-3%	-$101K	1.6%	23
2018 Q3	$3.46M	Sell	82,848 -5,955	-7%	-$229K	1.51%	22
2018 Q2	$3.06M	Buy	88,803 +817	+0.9%	+$27.9K	1.41%	26
2018 Q1	$2.96M	Sell	87,986 -843	-0.9%	-$29K	1.39%	26
2017 Q4	$3.05M	Sell	88,829 -1,476	-2%	-$50.3K	1.41%	26
2017 Q3	$3.06M	Sell	90,305 -5,188	-5%	-$167K	1.49%	26
2017 Q2	$3.04M	Sell	95,493 -2,372	-2%	-$74.8K	1.55%	25
2017 Q1	$3.18M	Sell	97,865 -275	-0.3%	-$8.67K	1.64%	23
2016 Q4	$3.02M	Buy	98,140 +2,010	+2%	+$61.4K	1.64%	24
2016 Q3	$3.09M	Buy	96,130 +1,164	+1%	+$38.9K	1.73%	22
2016 Q2	$3.17M	Buy	94,966 +2,259	+2%	+$72.1K	1.84%	22
2016 Q1	$2.61M	Sell	92,707 -12,530	-12%	-$358K	1.58%	26
2015 Q4	$3.22M	Sell	105,237 -3,794	-3%	-$119K	2%	19
2015 Q3	$3.25M	Sell	109,031 -3,057	-3%	-$98K	2.19%	19
2015 Q2	$3.57M	Sell	112,088 -5,112	-4%	-$167K	2.18%	20
2015 Q1	$3.87M	Buy	117,200 +159	+0.1%	+$5.05K	2.33%	15
2014 Q4	$3.46M	Buy	117,041 +418	+0.4%	+$12K	2.08%	20
2014 Q3	$3.27M	Buy	116,623 +209	+0.2%	+$5.87K	2.01%	19
2014 Q2	$3.28M	Sell	116,414 -3,874	-3%	-$110K	1.97%	21
2014 Q1	$3.67M	Sell	120,288 -1,001	-0.8%	-$29.8K	2.28%	17
2013 Q4	$3.52M	Buy	+121,289	New	+$3.53M	2.22%	17

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Glenview State Bank Trust Department's PFE Position: Q2 2021 in Review

Glenview State Bank Trust Department reduced its Pfizer (PFE) stake by 0.31% in Q2 2021, selling an estimated $10.7K and leaving 87,710 shares worth $3.43M. The position accounts for 1.05% of the portfolio, ranked #27.

Glenview State Bank Trust Department first reported a position in PFE in Q4 2013 and has held it in 31 quarters since. The position peaked at $3.87M in Q1 2015. 2,733 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

Glenview State Bank Trust Department held 87,710 shares of Pfizer worth $3.43M as of Q2 2021.
Glenview State Bank Trust Department sold 275 Pfizer shares in Q2 2021, an estimated $10.7K.
Pfizer made up 1.05% of Glenview State Bank Trust Department's portfolio in Q2 2021, its #27 holding.
Glenview State Bank Trust Department first reported a position in Pfizer in Q4 2013 and has held it in 31 quarters since.
Glenview State Bank Trust Department's Pfizer position peaked at $3.87M in Q1 2015.
2,733 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Glenview State Bank Trust Department's 13F filing for Q2 2021, filed 28 Jul 2021.